Myth #1: Peptides are completely safe
Different peptide classes have different safety profiles. GLP-1s have boxed warnings. GH peptides affect insulin sensitivity. Melanotan 2 has melanoma concerns. There is no “universal peptide safety.”
Myth #2: Peptides work as well as steroids
For lean mass gain, anabolic steroids produce effect sizes 3-5x larger than even the most aggressive peptide stacks in controlled comparisons. Peptides have different value propositions (recovery, longevity, cleaner side effects).
Myth #3: Oral peptides work as well as injected
Most peptides have <1% oral bioavailability. Oral semaglutide (Rybelsus) at 14mg approximates 0.5mg injected.
Myth #4: All research peptide suppliers are equivalent
Quality varies dramatically. Independent testing of “research peptide” vials has shown actual peptide content ranging from 30% to 100% of labeled.
Myth #5: WADA-banned means dangerous
WADA banning relates to performance enhancement, not safety. Many WADA-banned peptides have clean safety profiles in clinical research.
Myth #6: Higher dose = better results
Most peptides have plateau effects. Higher doses often increase side effects without proportional benefit. Receptor saturation occurs.
Myth #7: You can use any peptide forever
Many peptides require cycling to prevent receptor desensitization. Continuous use of GHRPs causes diminishing returns.
Are peptides natural?
Endogenous peptides are; synthetic analogs are not. Effect size and safety vary.